A drug and consumer products company has been ordered to pay Sh473 billion to 22 women who claim the firm’s powder contributed to them developing ovarian cancer.
Bold Reporting Takes Time, Courage and Investment. Stand With Us.
- Unlimited access to all premium content
- Uninterrupted ad-free browsing experience
- Mobile-optimized reading experience
- Weekly Newsletters
- MPesa, Airtel Money and Cards accepted